HCPCS Level II · Drugs administered other than oral method
J7677Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7677
J7677 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram.
It was added to HCPCS effective 07/01/2019.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Revefenacin inh non-com 1mcg
- Date added
- 07/01/2019
- Action effective
- 07/01/2019
- BETOS
- D1G
Related J76xx codes
- J7601Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
- J7604Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
- J7605Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
- J7606Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
- J7607Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
- J7608Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
- J7609Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
- J7610Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
- J7611Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
- J7612Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
- J7613Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
- J7614Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg
Common questions about J7677
Is HCPCS J7677 still valid?
- Yes. J7677 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J7677?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.